| Linda Parrish, CCC-SLP | |
|
95 Summer Court, American Falls, ID 83211 | |
| (916) 509-5812 | |
| Not Available |
| Full Name | Linda Parrish |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 95 Summer Court, American Falls, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316398373 | NPI | - | NPPES |
| SLP-3166 | Other | ID | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP-3166 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Linda Parrish, CCC-SLP 95 Summer Court, American Falls, ID 83211 Ph: (916) 509-5812 | Linda Parrish, CCC-SLP 95 Summer Court, American Falls, ID 83211 Ph: (916) 509-5812 |
News Archive
A new study suggests that Alzheimer's disease may contribute to close to as many deaths in the United States as heart disease or cancer. The research is published in the March 5, 2014, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Nanomix Inc., a leading nanotechnology company focused on development of next generation point of care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings, announced today that the United States Patent and Trademark Office has allowed a patent application relating to flexible nanostructure electronic devices, such as nanotube sensors and transistors, and method for fabricating the same.
The next generation of drug therapies and enhanced treatment approaches for various forms of lymphoma are evolving as researchers continue to better understand how these cancers progress. Research will be presented today at the 52nd Annual Meeting of the American Society of Hematology introducing promising new options for the standard treatment of advanced asymptomatic follicular lymphoma, mantle cell lymphoma, and early, unfavorable (referring to patients with clinical stage I or II disease and one or more risk factors) Hodgkin disease.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of suggested guidelines on establishing research partnerships with patients.
Doctors at the Peter Munk Cardiac Centre today performed a minimally invasive surgical procedure to treat high blood pressure, called renal denervation, for the first time in Canada.
› Verified 4 days ago